QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
NYSEAMERICAN:ZOM

Zomedica - ZOM Stock Forecast, Price & News

$0.28
0.00 (0.00%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.28
$0.29
50-Day Range
N/A
52-Week Range
$0.15
$0.50
Volume
3.41 million shs
Average Volume
16.93 million shs
Market Capitalization
$277.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

Zomedica MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
2,020.9% Upside
$6.00 Price Target
Short Interest
Bearish
9.34% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.02) to ($0.17) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.40 out of 5 stars

ZOM stock logo

About Zomedica (NYSEAMERICAN:ZOM) Stock

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Receive ZOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zomedica and its competitors with MarketBeat's FREE daily newsletter.

ZOM Stock News Headlines

Zomedica (NYSEAMERICAN:ZOM) Shares Up 3.1%
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Zomedica to Present at LD Micro Main Event XV Conference
"TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race
Did you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution.
Here's What's Going On With Zomedica Shares
See More Headlines
Receive ZOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zomedica and its competitors with MarketBeat's FREE daily newsletter.

ZOM Company Calendar

Last Earnings
11/14/2022
Today
2/06/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:ZOM
CIK
N/A
Fax
N/A
Employees
47
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.00
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+2,020.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-18,380,000.00
Net Margins
-104.92%
Pretax Margin
-126.81%

Debt

Sales & Book Value

Annual Sales
$4.13 million
Book Value
$0.28 per share

Miscellaneous

Free Float
957,411,000
Market Cap
$277.23 million
Optionable
Not Optionable
Beta
0.95

Key Executives

  • Mr. Larry C. Heaton II (Age 66)
    Pres & CEO
    Comp: $488k
  • Ms. Ann Marie Cotter CPA (Age 54)
    Chief Financial Officer
    Comp: $273.66k
  • Mr. Adrian Lock (Age 62)
    VP, GM & Head of Sales
    Comp: $126.47k
  • Mr. Anthony K. Blair (Age 62)
    Chief Operating Officer
  • Mr. Evan St. Peter
    VP of Technology Innovation
  • Ms. Karen DeHaan-Fullerton J.D. (Age 55)
    Gen. Counsel, Chief Counsel & Corp. Sec.
  • Ms. Nicole Westfall
    VP of Marketing
  • Ms. Kristin Domanski
    VP of HR
  • Dr. Stephanie Laine Morley D.V.M. (Age 48)
    DVM, Consultant
  • Dr. William Carpenter MacArthur (Age 60)
    Consultant













ZOM Stock - Frequently Asked Questions

Should I buy or sell Zomedica stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zomedica in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZOM shares.
View ZOM analyst ratings
or view top-rated stocks.

What is Zomedica's stock price forecast for 2023?

1 brokerages have issued 12-month price targets for Zomedica's shares. Their ZOM share price forecasts range from $6.00 to $6.00. On average, they predict the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 2,001.6% from the stock's current price.
View analysts price targets for ZOM
or view top-rated stocks among Wall Street analysts.

When is Zomedica's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our ZOM earnings forecast
.

How were Zomedica's earnings last quarter?

Zomedica Corp. (NYSEAMERICAN:ZOM) posted its quarterly earnings data on Monday, November, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $4.78 million during the quarter. Zomedica had a negative net margin of 104.92% and a negative trailing twelve-month return on equity of 6.51%.

What is Zomedica's stock symbol?

Zomedica trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ZOM."

Who are Zomedica's major shareholders?

Zomedica's stock is owned by a number of institutional and retail investors. Top institutional investors include Pinnacle Wealth Management Group Inc. (0.10%). Insiders that own company stock include Ann Marie Cotter, Christopher Ross Macleod, Johnny D Powers, Robert Cohen and Stephanie Morley.
View institutional ownership trends
.

How do I buy shares of Zomedica?

Shares of ZOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zomedica's stock price today?

One share of ZOM stock can currently be purchased for approximately $0.29.

How much money does Zomedica make?

Zomedica (NYSEAMERICAN:ZOM) has a market capitalization of $279.78 million and generates $4.13 million in revenue each year. The company earns $-18,380,000.00 in net income (profit) each year or ($0.02) on an earnings per share basis.

How can I contact Zomedica?

Zomedica's mailing address is 100 PHOENIX DRIVE SUITE 125, ANN ARBOR MI, 48108. The official website for the company is www.zomedica.com. The company can be reached via phone at 734-369-2555 or via email at investors@zomedica.com.

This page (NYSEAMERICAN:ZOM) was last updated on 2/6/2023 by MarketBeat.com Staff